<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Physiology Anatomy and Genetics</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8785E853-AF63-4587-BFD8-1C96C822ADAE"><gtr:id>8785E853-AF63-4587-BFD8-1C96C822ADAE</gtr:id><gtr:firstName>Anant</gtr:firstName><gtr:otherNames>Bhikhu</gtr:otherNames><gtr:surname>Parekh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000813"><gtr:id>C9686A08-9C53-4264-B411-C67027138DB0</gtr:id><gtr:title>CRAC channel-dependent calcium microdomains and mast cell function in health and disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000813</gtr:grantReference><gtr:abstractText>The last 20 years have seen a marked rise in allergy sufferers in the U.K. Allergies come in various disguises but two particularly common ones are asthma and allergic rhinitis/nasal polyposis. Recent figures indicate that almost 30% of the U.K. population suffer, at some time, from allergic rhinitis and polyposis, ailments that result in inflammation within the nose, with serious consequences on quality of life including full nasal obstruction and complete loss of smell. These disorders arise from a trigger-happy immune system, with the main culprit being the mast cell. Effective treatment of these medical problems requires detailed understanding of fundamental processes in cell physiology and the application of this to mast cells may lead to new therapies for combating allergies. It is known that an increase in calcium activates the mast cell, as it does in virtually all animal cells, and that the calcium rise causes the mast cell to release a battery of chemicals that recruit and stimulate other immune cells, blood vessels and airway muscle. If unchecked, this can produce substantial local tissue damage. Like other cells, mast cells can increase their calcium levels in one of two ways: calcium can enter from outside the cell or it can be released from storage sacs inside the cell. These storage sacs contain only a small amount of calcium and it is calcium entry into the mast cell that is key for maintaining the responses. Calcium entry is controlled by tiny pores in the cell surface that open or close in response to internal signals. These pores are called the CRAC channel. Animals lacking the CRAC channel have severely compromised mast cell function. The aim of this proposal is to understand how, at a very fundamental level, the CRAC channel activates human nasal mast cells and how the channel and subsequent mast cell responses change in allergy. This work will enhance our understanding of mast cells, and how they are regulated. It will also shed new light on what happens when things go wrong with these cells and may identify new therapeutic targets for drug therapy for allergic disorders.</gtr:abstractText><gtr:technicalSummary>Allergies in the U.K. have reached epidemic proportions, with conservative estimates indicating that almost one in three people are affected. In addition to the direct costs (~ 1 billion pounds each year is spent on treating allergies), the socio-economic costs are substantial with around 13 million working days lost each year and academic performance of allergy sufferers in schools is considerably lower than their non-affected peers. Mast cells are intimately involved in the initiation and maintenance of allergic responses. Allergen-induced activation of mast cells opens store-operated CRAC channels in the plasma membrane and the subsequent Ca2+ microdomains leads to exocytosis of histamine-containing granules, synthesis and secretion of pro-inflammatory lipid-derived signals, and increased expression of genes coding for chemokines and cytokines. The molecular composition and properties of the CRAC channel in human mast cells and how calcium microdomains (accompanying CRAC channel opening) activate spatially and temporally distinct responses is unknown. Using state-of-the-art methods, we will compare CRAC channels properties and subsequent exocytosis in mast cells from normal individuals with patients suffering from severe allergic rhinitis to establish how the response pattern has changed in the diseased state. Collectively, this programme should lead to the identification of new therapeutic targets for drugs aimed at combating this growing health crisis.</gtr:technicalSummary><gtr:fund><gtr:end>2014-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>825803</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit-Oxford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>95807D7D-2729-4F4D-990A-8E02423DDC8A</gtr:id><gtr:impact>I delivered a lecture to 6th formers from various schools in the Oxford area on Medical research and then had question-answer type discussion with several of them. In additon, our work was presented on TV (local news) and the Radio (January 2009).

This has led to sixth formers spending 2-3 weeks each summer in my laboratory shadowing researchers.</gtr:impact><gtr:outcomeId>19145CDFEE0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1CFB4C59-2C1A-468A-8F88-27272C337EEF</gtr:id><gtr:impact>10 6th formers attended a talk on Biomedical sciences at University.

6th formers have expressed interest in spending a week working in the lab</gtr:impact><gtr:outcomeId>oiWueYzGHty</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Call for Asthma</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>American Asthma Foundation</gtr:fundingOrg><gtr:id>1AA7ACA4-729C-4AD1-8B28-48C044AF048E</gtr:id><gtr:outcomeId>aFJZGQLtgww</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Population and Systems Medicine Board</gtr:description><gtr:end>2019-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>356CBC73-78E9-4639-B7C6-B760DE8766F8</gtr:id><gtr:outcomeId>BVzEex2ZQHK</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A combination therapy for treating allergy</gtr:description><gtr:grantRef>G1000813</gtr:grantRef><gtr:id>B8AD82BF-BDB2-49B9-8829-247723A743D0</gtr:id><gtr:impact>The discovery has attracted interest from Venture Capitalists</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>RhgiwLd71Z1</gtr:outcomeId><gtr:patentId>WO200909571</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Combination therapy for treating mast cell disorders</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>867A3BDF-D58B-4BD3-A5C7-4173596E4366</gtr:id><gtr:title>Mast cell CRAC channel as a novel therapeutic target in allergy.</gtr:title><gtr:parentPublicationTitle>Current opinion in allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d510ff2f939372dc22b78d9c41e36bba"><gtr:id>d510ff2f939372dc22b78d9c41e36bba</gtr:id><gtr:otherNames>Di Capite JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1473-6322</gtr:issn><gtr:outcomeId>qHoBvMG96yh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D24A0E26-F79F-4FCA-AEB9-C5DBECF1347F</gtr:id><gtr:title>Key role for store-operated Ca2+ channels in activating gene expression in human airway bronchial epithelial cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ac3af8bbe43cd57a0ccda8a7fd945f4"><gtr:id>2ac3af8bbe43cd57a0ccda8a7fd945f4</gtr:id><gtr:otherNames>Samanta K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54577268d086b4.03711767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>478653B6-1269-4E7C-8F1E-F1143A7F9D7F</gtr:id><gtr:title>Dynamic assembly of a membrane signaling complex enables selective activation of NFAT by Orai1.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64f00c47b4318da203773aa44f21b46"><gtr:id>c64f00c47b4318da203773aa44f21b46</gtr:id><gtr:otherNames>Kar P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>5457726878d152.31760100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB288A23-AFC1-41F6-A651-4F7082751B4D</gtr:id><gtr:title>Selective activation of the transcription factor NFAT1 by calcium microdomains near Ca2+ release-activated Ca2+ (CRAC) channels.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64f00c47b4318da203773aa44f21b46"><gtr:id>c64f00c47b4318da203773aa44f21b46</gtr:id><gtr:otherNames>Kar P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>arnFKfhEi56</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ECFC49C-33A3-4EB4-A635-237380DA901A</gtr:id><gtr:title>Endoplasmic reticulum-mitochondria coupling: local Ca&amp;sup2;? signalling with functional consequences.</gtr:title><gtr:parentPublicationTitle>Pflugers Archiv : European journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c713027840f07c867742f73d18f4ecc4"><gtr:id>c713027840f07c867742f73d18f4ecc4</gtr:id><gtr:otherNames>Bakowski D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0031-6768</gtr:issn><gtr:outcomeId>pm_15829_29_22415215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C553D5D1-065C-4AC5-996F-20333B53DB72</gtr:id><gtr:title>Cysteinyl leukotriene type I receptor desensitization sustains Ca2+-dependent gene expression.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f47783f0dd096f8101156df927a5120"><gtr:id>6f47783f0dd096f8101156df927a5120</gtr:id><gtr:otherNames>Ng SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>p8mCLsgctYc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FB03F45-AA5E-4A45-92F4-9656B008C049</gtr:id><gtr:title>Decoding cytosolic Ca2+ oscillations.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0db233d7aec9c2f0a761f10a7651e52"><gtr:id>a0db233d7aec9c2f0a761f10a7651e52</gtr:id><gtr:otherNames>Parekh AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>kdg2bv7VbPp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23708FD0-13DC-40C7-ADE9-F385A6E4A088</gtr:id><gtr:title>CRAC channels drive digital activation and provide analog control and synergy to Ca(2+)-dependent gene regulation.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64f00c47b4318da203773aa44f21b46"><gtr:id>c64f00c47b4318da203773aa44f21b46</gtr:id><gtr:otherNames>Kar P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>pm_15829_29_22245003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F22E094-6312-492A-BC82-922CA3BAED40</gtr:id><gtr:title>Different agonists recruit different stromal interaction molecule proteins to support cytoplasmic Ca2+ oscillations and gene expression.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64f00c47b4318da203773aa44f21b46"><gtr:id>c64f00c47b4318da203773aa44f21b46</gtr:id><gtr:otherNames>Kar P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15829_29_22509043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF472A98-8C8E-4FCB-B5C1-D9FEEEC2C0CE</gtr:id><gtr:title>Caveolin-1 alters the pattern of cytoplasmic Ca2+ oscillations and Ca2+-dependent gene expression by enhancing leukotriene receptor desensitization.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/672c8408c4274a71582d7e61315193bc"><gtr:id>672c8408c4274a71582d7e61315193bc</gtr:id><gtr:otherNames>Yeh YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>54577268517257.23282365</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A64FC96-0166-4F13-B7FC-A54E96042F84</gtr:id><gtr:title>Mitofusin 2 regulates STIM1 migration from the Ca2+ store to the plasma membrane in cells with depolarized mitochondria.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85fc009119d8abdf965f3cab83c9f2a5"><gtr:id>85fc009119d8abdf965f3cab83c9f2a5</gtr:id><gtr:otherNames>Singaravelu K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>Xfcfyo58REP</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000813</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>